Miron Lila

Vice President and Head of Corporate Development & Investor Relations

Miron Lila is Vice President and Head of Corporate Development & Investor Relations at Caidya. In this role, he is responsible for supporting key financing and strategic initiatives, identifying partnership opportunities to accelerate the company’s global growth, coordinating investor communication efforts, and working with the senior management team to build a robust investor relations strategy. Additionally, he oversees Caidya’s global Accounting/Reporting and Treasury functions.

With over fifteen years of healthcare-focused corporate finance, capital markets, and mergers and acquisitions experience, Miron brings a wealth of expertise to his role. Prior to joining Caidya, he served as a senior healthcare investment banker and team head at Citi, where he played a key role in establishing Citi’s healthcare franchise in Asia. During his tenure, Miron developed a broad spectrum of senior-level client and industry relationships in the biopharma & healthcare sector, with a unique geographic scope covering Greater China, Korea, and Southeast Asia. He successfully completed over 30 transactions across all investment banking products, amounting to a total deal value of US$15 billion.

Miron holds a BSc. in Government and Economics from the London School of Economics and Political Science. He is also a member of the Hong Kong Stock Exchange Listing Committee, which acts as both an independent administrative decision-maker and an advisory body for the Exchange, where he was appointed in July 2022.

Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.

Life Science Innovation Northwest

17th April 2024 to 18th April 2024
Seattle, WA

04/01/2024

Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto

Morrisville, NC, USA, April 1, 2024 - Caidya, a leading...

American Association for Cancer Research (AACR)

5th April 2024 to 10th April 2024
San Diego, CA